Skip to main content

Advertisement

Log in

The role of the determination of the CD20 antigen through quantitative flow cytometry in complex cases of rheumatoid arthritis treated with anti-TNF-α

  • Case Report
  • Published:
Rheumatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Ginaldi L, De Martinis M et al (1998) Levels of expression of CD19 and CD20 in chronic B cell leukaemias. J Clin Pathol 51:364–369

    Article  PubMed  CAS  Google Scholar 

  2. Golay J, Lazzari M et al (2001) CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukaemia: further regulation by CD55 and CD59. Blood 98:12:3383–3389

    Article  Google Scholar 

  3. Panayi GS, Hainsworth JD, Looney RJ, Keystone EC (2005) Panel discussion on B cells and rituximab: mechanistic aspects, efficacy and safety in rheumatoid arthritis and non-Hodgkin’s lymphoma. Rheumatology 44(Suppl 2):ii18–ii20

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Bihl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hobi, A., Bihl, T., Fellay, B. et al. The role of the determination of the CD20 antigen through quantitative flow cytometry in complex cases of rheumatoid arthritis treated with anti-TNF-α. Rheumatol Int 26, 1161–1162 (2006). https://doi.org/10.1007/s00296-006-0139-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-006-0139-y

Keywords

Navigation